ロード中...
Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
The aim of this study was to assess the clinical evidence for platinum-Taxol non-cross-resistance in patients with epithelial ovarian cancer. Unlike other studies, only patients who had demonstrably progressive disease on platinum therapy were analysed. Patients received 135-200 mg m-2 of Taxol over...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2033816/ https://ncbi.nlm.nih.gov/pubmed/7779729 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|